Abstract
The national pharmacovigilance program in Malaysia is limited to very few centers and under-reporting of adverse drug reactions (ADRs) is a major limitation. Studies from developed countries have documented the importance and usefulness of consumer reporting of ADRs. Involving consumers in ADR reporting can be very useful in improving the reporting rates in Malaysia. The present article highlights the proposed plan of initiating a consumer based pharmacovigilance program in University Wellness Center located inside the campus of the Universiti Sains Malaysia, Penang, Malaysia.
This is a preview of subscription content, log in via an institution to check access.
References
Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009;4(2):e4439.
Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf. 2007;2(1):79–87.
World Health Organization. Requirements for adverse reaction reporting. Geneva, Switzerland: World Health Organization; 1975.
World Health Organization. The importance of pharmacovigilance. Geneva, Switzerland: World Health Organization; 2002.
Haq ASM. Pharmacovigilance initiatives in Malaysia. Drug Info J. 2008;37:143 (S)–148 (S).
Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf. 2007;16(2):223–8.
Fernandopulle RBM, Weerasuriya K. What can consumer adverse drug reaction reporting add to existing health professional-based systems. Drug Saf. 2003;26:219–25.
Langen J, van Hunsel F, Passier A, Van den Berg L, Van Grootheest K. Adverse drug reactions reporting by patients in the Netherlands. Drug Saf. 2008;31(6):515–24.
Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and internationale experience. Br J Clin Pharmacol. 2006;63(2):148–56.
Medawar C, Herxheimer A. A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Int J Risk Saf Med. 2003;16:5–19.
Al-Haddad M, Izham MIM. The development of the discipline of social and administrative pharmacy at Universiti Sains Malaysia. South Med Rev. 2008;1:3–5.
Palaian S, Izham M, Mishra P. Monitoring adverse drug reactions using the community pharmacists: a preliminary study from Nepal. Drug Saf. 2008;31(10):885–960.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229–32.
Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27:538.
Conflict of interests
There was no conflict of interest influencing the publication of this article.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
Adverse Drug Reaction Reporting Form
Rights and permissions
About this article
Cite this article
Palaian, S., Alshakka, M. & Mohamed Izham Developing a consumer reporting program in Malaysia: a novel initiative to improve pharmacovigilance. Pharm World Sci 32, 2–6 (2010). https://doi.org/10.1007/s11096-009-9342-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-009-9342-8